Emily Otto, CRNP, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 555 Delaware Ave, Palmerton, PA 18071 Phone: 484-426-2001 Fax: 484-426-2004 |
Karen Burke, Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 135 Lafayette Ave, Palmerton, PA 18071 Phone: 610-826-1340 |
Britta Hansen, CRNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 614 Delaware Ave, Palmerton, PA 18071 Phone: 484-822-6324 Fax: 866-230-8028 |
Rhyan A Goldsmith, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 614 Delaware Avenue, Palmerton, PA 18071 Phone: 484-822-5324 Fax: 833-230-8028 |
Melinda Wentz, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 135 Lafayette Ave, Palmerton, PA 18071 Phone: 484-822-5320 |
Ann E Acevedo, CRNP Nurse Practitioner - Gerontology Medicare: Accepting Medicare Assignments Practice Location: 218a Delaware Ave, Palmerton, PA 18071 Phone: 610-826-6353 |
Kelly Connelly, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 528 Delaware Ave, Palmerton, PA 18071 Phone: 610-900-4950 |
Bethany Marie Lengel, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 614 Delaware Ave, Palmerton, PA 18071 Phone: 424-822-8324 Fax: 866-230-8028 |
Mrs. Stacey Ann Connell, APRN,BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 218a Delaware Avenue, Palmerton, PA 18071 Phone: 610-826-6353 Fax: 610-826-6359 |
News Archive
"The United Nations independent expert on access to water and sanitation as a human right on Saturday urged States to allocate more resources to improving sanitation and promote efficient use of existing hygiene facilities, stressing that people are entitled to decent toilets," the U.N. News Centre reports.
A team led by investigators at Brigham and Women's Hospital has stated that cardiology patients should be warned and counseled about the potential risks of using marijuana until further evidence is available.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
Watson Pharmaceuticals, Inc. today announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating Hormone. The product is currently in preclinical development as a biosimilar molecule for the treatment of female infertility.
› Verified 7 days ago